Sunshield Reappoints Cyrus Poonevala as Independent Director
Sunshield Chemicals Limited's Board has approved the reappointment of Mr. Cyrus Poonevala as an Independent Director for a second five-year term starting January 15, 2027, pending shareholder approval at the upcoming AGM.

*this image is generated using AI for illustrative purposes only.
Sunshield Chemicals Limited announced that its Board of Directors has approved the reappointment of Mr. Cyrus Poonevala as an Independent Director. The decision was taken during a Board meeting held on May 13, 2026, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. The reappointment is based on the recommendation of the company's Nomination and Remuneration Committee.
Mr. Poonevala has been reappointed for a second term of five years, effective from January 15, 2027, until January 14, 2032. This appointment is subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the company. Mr. Poonevala was initially appointed for a term ending on January 14, 2027.
| Reappointment Details | Particulars |
|---|---|
| Director Name | Mr. Cyrus Poonevala |
| DIN | 09420865 |
| New Term Start Date | January 15, 2027 |
| New Term End Date | January 14, 2032 |
| Approval Status | Subject to Shareholder Approval at AGM |
Mr. Cyrus Poonevala is an experienced Aircraft Engineer with over 30 years of experience in the aviation industry, with a specific focus on maintenance. The company stated that his experience enables him to provide balanced guidance and contribute to the Board in matters relating to operations, risk oversight, and governance. He is not related to any of the existing Directors of the company and is not debarred from holding the office of Director by virtue of any SEBI order or any other authority.
Historical Stock Returns for Sunshield Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.40% | +5.18% | +16.97% | -9.26% | +16.97% | +243.60% |
With borrowings fully repaid and a debt-free balance sheet, how does Sunshield Chemicals plan to deploy its strengthened equity base for future capacity expansion or acquisitions?
Given the significant margin improvement in FY26, what are the key product segments or export markets driving profitability, and can this momentum be sustained amid global specialty chemicals competition?
Will the conservative dividend payout of ₹3 per share (roughly 8% of EPS) signal a shift toward reinvestment-led growth, and could shareholders expect higher dividends as cash generation improves?


































